| 84.87 -0.32 (-0.38%) | 04-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 103.56 |
1-year : | 106.47 |
| Resists | First : | 88.66 |
Second : | 91.16 |
| Pivot price | 87.28 |
|||
| Supports | First : | 84.63 |
Second : | 70.42 |
| MAs | MA(5) : | 85.21 |
MA(20) : | 87.93 |
| MA(100) : | 85.44  |
MA(250) : | 81.61 |
|
| MACD | MACD : | -1.1 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 3.5 |
D(3) : | 2.9 |
| RSI | RSI(14): 25.4 |
|||
| 52-week | High : | 91.16 | Low : | 74.05 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PPH ] has closed above bottom band by 14.7%. Bollinger Bands are 81.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 85.47 - 85.94 | 85.94 - 86.33 |
| Low: | 83.15 - 83.83 | 83.83 - 84.39 |
| Close: | 83.87 - 84.88 | 84.88 - 85.7 |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Wed, 17 Apr 2024
The 5 Best Pharmaceutical ETFs of 2023 - etf.com
Fri, 08 Mar 2024
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Thu, 07 Mar 2024
The Top 3 ETFs to Buy in March 2024 - InvestorPlace
Mon, 26 Feb 2024
The 3 Hottest Healthcare ETFs to Buy in 2024 - InvestorPlace
Mon, 12 Feb 2024
A Look at Pharma ETFs After Q4 Earnings - Yahoo Finance
Fri, 19 Jan 2024
VanEck Pharmaceutical ETF (PPH): Ignore The Election Scare, Buy Pharma & Healthcare - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|